Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 5/2002

Content (7 Articles)

Review

The role of CD8+ T cells in immune responses to colorectal cancer

Liviu V. Titu, John R. Monson, John Greenman

Original Article

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer

Supriya Perambakam, Bao-Hua Xue, Jeffrey A. Sosman, David J. Peace

Original Article

Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-Aff24-recoverin tetramer

Shunshui Rong, Hideyuki Ikeda, Yuriko Sato, Yoshihiko Hirohashi, Yukio Takamura, Hiroeki Sahara, Takashi Sato, Akiko Maeda, Hiroshi Ohguro, Noriyuki Sato

Letter to the Editor

Is the presence of interleukin-2 receptor alpha in the serum of colorectal liver metastases patients derived from hepatic natural killer cells?

David Vermijlen, Dianzhong Luo, Mogens Kruhøffer, Torben F. Ørntoft, Peter J. K. Koppen, Eddie Wisse

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine